Molecular Partners AG ADR Cash Flow-to-Debt Ratio
Molecular Partners AG ADR cash flow-to-debt ratio. Molecular Partners AG ADR (MOLN) has a Cash Flow-to-Debt Ratio of -0.63x as of June 2026, meaning its operating cash flow of $-10.81 Million could theoretically repay -1% of its total liabilities ($17.09 Million) in one year. Check cash flow quality index of Molecular Partners AG ADR to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Molecular Partners AG ADR (2013–2025)
Cash flow-to-debt ratio of Molecular Partners AG ADR from 2013 to 2025. Historical debt coverage capacity for Molecular Partners AG ADR across 13 annual periods. Check Molecular Partners AG ADR (MOLN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Molecular Partners AG ADR Cash Flow-to-Debt Ratio by Year (2013–2025)
Molecular Partners AG ADR cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Molecular Partners AG ADR. For the full cash flow conversion analysis, see cash flow conversion of Molecular Partners AG ADR.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.35x | $-51.26 Million | $21.77 Million | ▲ +32.9% |
| 2024 | -3.51x | $-59.25 Million | $16.89 Million | ▼ -30.3% |
| 2023 | -2.69x | $-59.01 Million | $21.92 Million | ▼ -161.5% |
| 2022 | 4.38x | $118.57 Million | $27.09 Million | ▲ +414.6% |
| 2021 | -1.39x | $-90.95 Million | $65.38 Million | ▼ -285.6% |
| 2020 | -0.36x | $-28.98 Million | $80.33 Million | ▼ -1441.5% |
| 2019 | -0.02x | $-1.19 Million | $50.80 Million | ▲ +96.5% |
| 2018 | -0.67x | $-42.47 Million | $63.45 Million | ▲ +53.7% |
| 2017 | -1.45x | $-40.02 Million | $27.69 Million | ▼ -97.3% |
| 2016 | -0.73x | $-35.38 Million | $48.30 Million | ▼ -286.9% |
| 2015 | 0.39x | $26.50 Million | $67.60 Million | ▲ +257.5% |
| 2014 | -0.25x | $-11.33 Million | $45.54 Million | ▼ -13.0% |
| 2013 | -0.22x | $-13.61 Million | $61.80 Million | — |